Therapure Biopharma Inc. Files Preliminary Prospectus For Initial Public Offering

MISSISSAUGA, Ontario--(BUSINESS WIRE)--Therapure Biopharma Inc. today announces that it has filed a preliminary prospectus with securities regulatory authorities in each of the provinces and territories of Canada in connection with a proposed initial public offering (the “Offering”) of its common shares. A copy of the preliminary prospectus is available on SEDAR (www.sedar.com).

The Offering is being made through a syndicate of underwriters co-led by GMP Securities L.P., CIBC World Markets Inc. and National Bank Financial Inc.